The CSIR has acquired the reports to 14 clinical studies in which Hoodia has been assesses, using crude extracts and concentrated active ingredients formulated in a number of different ways. In many of the studies Hoodia was found to be generally safe and well tolerated, though in some subjects’ adverse events and tolerability issues were noted with the concentrated active ingredient extracts. During the periods 1999 to 2003 clinical studies performed by the licensee or its partners were not published however detailed clinical studies were produced on the studies. A synopsis of the findings of the key clinical performed during this period is made available through the CSIR web-based ResearchSpace
